Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis

Cancer Lett. 1998 Dec 25;134(2):181-6. doi: 10.1016/s0304-3835(98)00252-3.

Abstract

The HBx protein of hepatitis B virus has been shown to induce hepatocellular carcinoma in transgenic mice as direct evidence for its involvement in hepatocarcinogenesis. In these transgenic mice, however, it is not clear why hepatocytes do not acquire a neoplastic phenotype by 13 months old despite the continuous growth stimulation by the HBx protein from 2 months old. In this study, we show that the accelerated proliferation of hepatocytes is counterbalanced by apoptosis, which maintains liver homeostasis. A decrease in the extent of apoptosis seems to precede the emergence of neoplasia in the transgenic mouse liver. The disappearance or block of apoptotic signals, which may be the result of additional genetic or epigenetic aberrations, may result in the preneoplastic hepatocytes becoming neoplastic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / metabolism
  • Animals
  • Apoptosis*
  • Disease Models, Animal
  • Hepatitis B Antigens / metabolism*
  • Hepatitis B virus / immunology*
  • In Situ Nick-End Labeling
  • Liver Neoplasms, Experimental / genetics
  • Liver Neoplasms, Experimental / pathology*
  • Liver Neoplasms, Experimental / virology*
  • Male
  • Mice
  • Mice, Transgenic
  • Phenotype
  • Precancerous Conditions / genetics
  • Precancerous Conditions / pathology*
  • Trans-Activators / metabolism*
  • Viral Regulatory and Accessory Proteins

Substances

  • Hepatitis B Antigens
  • Trans-Activators
  • Viral Regulatory and Accessory Proteins
  • hepatitis B virus X protein